[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339545-105":59,"doc-detail-339545-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-potential-value-of-cancer-testis-antigens-in-ovarian-cancer-prognostic-markers-and-targets-for-immunotherapy","The potential value of cancer-testis antigens in ovarian cancer - Prognostic markers and targets for immunotherapy","","Tumor immunotherapy has emerged as a key adjuvant after surgery, radiotherapy, and chemotherapy. This review evaluates cancer-testis antigens (CTA), a tumor-associated antigen with restricted expression across cancers and strong ability to trigger immune responses, in ovarian cancer. It analyzes publication evidence and summarizes regulatory mechanisms, immunogenicity, clinical expression significance, tumorigenesis, and prospects, with emphasis on recent CTA-based immunotherapy progress.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-potential-value-of-cancer-testis-antigens-in-ovarian-cancer-prognostic-markers-and-targets-for-immunotherapy/339545/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-potential-value-of-cancer-testis-antigens-in-ovarian-cancer-prognostic-markers-and-targets-for-immunotherapy/339545.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the review on ovarian cancer?","Question",{"text":112,"@type":113},"The review focuses on the potential value of cancer-testis antigens (CTA) in ovarian cancer, including their roles as prognostic markers and therapeutic targets for immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the paper describe CTA in relation to tumor immunotherapy?",{"text":117,"@type":113},"CTA is described as a tumor-associated antigen that is highly restricted in various tumors and can induce immune responses, making it promising for diagnosis, prognosis evaluation, and antitumor immunotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationships does the review report between CTA and ovarian cancer outcomes?",{"text":121,"@type":113},"The review states that CTA expression affects the occurrence, development, and prognosis of ovarian cancer and is closely related to tumor immunity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339545,1790154884,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","DOI: 10.1002/iid3.1284  \nREV I EW ARTICLE  \nThe potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy  \nLina Lin1,2  | Xiaoqiong Zou1 | Weixia Nong1 | Yingying Ge1 | Feng Li1 | Bin Luo1,3 | Qingmei Zhang1,3 | Xiaoxun Xie1,3,4  \n1Department of Histology and Embryology, School of Basic Medicine Science, Guangxi Medical University, Nanning, Guangxi, People's Republic of China  \n2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China  \n3Education Department of Guangxi Zhuang Autonomous Region, Key Laboratory of Basic Research on Regional Diseases (Guangxi Medical University), Nanning, Guangxi, People's Republic of China  \n4Ministry of Education, Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor (Guangxi Medical University), Nanning, Guangxi, People's Republic of China  \nCorrespondence  \nXiaoxun Xie, Department of Histology and Embryology, School of Basic Medicine Science, Guangxi Medical University,  \n22 Shuangyong Rd., Nanning 530021, Guangxi, People's Republic of China.  \nEmail: [1695261181@qq.com](1695261181@qq.com)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Number: 81960453; Natural Science Foundation of Guangxi Province, Grant/Award Numbers:  \n2023GXNSFAA026120, 2022GXNSFAA035639; Innovation Project of Guangxi Graduate Education,  \nGrant/Award Number: YCBZ2023090  \nAbstract  \nBackground: Tumor immunotherapy has become an important adjuvant therapy after surgery, radiotherapy, and chemotherapy. In recent years, the role of tumor‐associated antigen (TAA) in tumor immunotherapy has become increasingly prominent. Cancer‐testis antigen (CTA) is a kind of TAA that is highly restricted in a variety of tumors and can induce an immune response. Aims: This review article aimed to evaluate the role ofCTA on the progression of ovarian cancer, its diagnostic efficacy, and the potential for immunotherapy. Methods: We analyzed publications and outlined a comprehensive of overview the regulatory mechanism, immunogenicity, clinical expression significance, tumorigenesis, and application prospects of CTA in ovarian cancer, with a particular focus on recent progress in CTA‐based immunotherapy.  \nResults: The expression of CTA affects the occurrence, development, and prognosis of ovarian cancer and is closely related to tumor immunity. Conclusion: CTA can be used as a biomarker for the diagnosis and prognosis evaluation of ovarian cancer and is an ideal target for antitumor immunotherapy. These findings provide novel insights on CTA in the improvement of diagnosis and treatment for ovarian cancer. The successes, current challengesand future prospects were also discussed to portray its significant potential.  \nKEYWORDS  \nCTA, ovarian cancer, tumor therapy  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.  \nImmun Inflamm Dis. 2024;12:e1284 . [https://doi.org/10.1002/iid3.1284](https://doi.org/10.1002/iid3.1284)  \n[wileyonlinelibrary.com/journal/iid3](wileyonlinelibrary.com/journal/iid3)  \n1 of 17  \n1 | INTRODUCTION  \nOvarian cancer is the deadliest gynecological malignancy, the second most common malignancy in women over the age of 40, and the fifth leading cause of cancer death in women.1 According to the latest statistics from the National Cancer Center, ovarian cancer accounts for approximately 2.93% of new cases and 2.24% of deaths in China each year.2 In the past decade, the mortality of ovarian cancer in China has shown an upward trend mainly because of its hidden onset and lack of accurate and effective early screening methods. More than 70% of patients are in the advanced stage of t","cbCaimEFNMKtp9GR","https://ap.wps.com/l/cbCaimEFNMKtp9GR","pdf",1342221,17,"English","# Introduction\n## Ovarian cancer burden and treatment limitations\n## Cancer-testis antigens as tumor-associated antigens\n# Abstract\n## Background and aims\n## Methods\n## Results and conclusion","[{\"question\":\"What is the main focus of the review on ovarian cancer?\",\"answer\":\"The review focuses on the potential value of cancer-testis antigens (CTA) in ovarian cancer, including their roles as prognostic markers and therapeutic targets for immunotherapy.\"},{\"question\":\"How does the paper describe CTA in relation to tumor immunotherapy?\",\"answer\":\"CTA is described as a tumor-associated antigen that is highly restricted in various tumors and can induce immune responses, making it promising for diagnosis, prognosis evaluation, and antitumor immunotherapy.\"},{\"question\":\"What relationships does the review report between CTA and ovarian cancer outcomes?\",\"answer\":\"The review states that CTA expression affects the occurrence, development, and prognosis of ovarian cancer and is closely related to tumor immunity.\"}]","The potential value of cancer-testis antigens in ovarian cancer - Prognostic markers and targets for immunotherapy | PDF",1790030960,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2f8774248f90953dd870e8355b1df3b.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd038111bd0fba084b00f8b63fc472e3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdfbe5656d142a0047c7f4226dc758e3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a38f1ecc5c2f461707e659b93d87bb1.webp",980,1287]